A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma

NCT05932290 · clinicaltrials.gov ↗

COMPLETED

Status

514

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Elranatamab
DRUG: Standard of care

Sponsor

Pfizer